CheckMyRecalls

Kowa Pharmaceuticals America recalls Livalo (pitavatstatin) tablets

Published
19 Mar 2025
Units affected
5,328 Bottles
Agency
FDA
Country
United States

The hazard

Presence of foreign tablets/capsules

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Livalo (pitavatstatin) tablets, 4 mg, 90-count bottles, Rx only, Manufactured by: Patheon, Inc. Cincinnati, OH 45237 USA or by Kowa Company, Ltd, Nagoya, 462-0024 Japan, Marketed by Kowa Pharmaceuticals: Kowa Pharmaceuticals America Inc., Montgomery, AL 36117 USA NDC 66869-404-90 HDPE Bottle, congregated into a shrink wrapped 6-pack further congregated into 24 6-packs in a cardboard case

Brand / company
Kowa Pharmaceuticals America
Codes / lots
Lot#: 3231300, Exp 8/2027
Distribution
PA, OH, and TX
Recall status
Completed

Source: U.S. Food and Drug Administration, published 19 Mar 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.